Brief: Isofol Posts New Study Results In Favor Of Arfolitixorin

Isofol Medical AB (publ)

05/07/2024 10:16

July 5 (Reuters) - Isofol Medical AB (publ)  ISOFOL.ST :
    * AN EXTERNAL COMMITTEE OF EXPERTS HAS PERFORMED A POST HOC
PER-PROTOCOL ANALYSIS OF CLINICAL PHASE III STUDY AGENT THAT
SHOWS NEW RESULTS IN FAVOR OF ARFOLITIXORIN

Source text for Eikon:  ID:nMFNbV23sf 
Further company coverage:  ISOFOL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))